PCCA gene therapy (Mayo Foundation)

N/A

Report date: 2025/01/26 15:14:45

Base Information

Drug NamePCCA gene therapy (Mayo Foundation)
Drug Alias NamePCCA gene therapy (Mayo Foundation)PCCA gene therapy (Mayo Foundation)PCCA gene therapy (Mayo Foundation)
ClassificationBiologics
Mechanisms of ActionPropionyl-CoA carboxylase alpha chain, mitochondrial stimulants
TargetsPropionyl-CoA carboxylase alpha chain, mitochondrial
Therapy Area/IndicationsPropionic Acidemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsPropionic Acidemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A